FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1597521231> ?p ?o ?g. }

• W1597521231 abstract "Background Sexual dysfunction is very common in patients with chronic kidney disease (CKD), but it is still significantly understudied. Treatment options exist but concerns have been raised relating to their efficacy and safety in CKD. Objectives We assessed the benefits and harms of existing interventions for treatment of sexual dysfunction in patients with CKD. Search methods In October 2010 we searched the Cochrane Renal Group's specialised register, CENTRAL (The Cochrane Library, issue 10), MEDLINE (from 1966) and EMBASE (from 1980). Selection criteria Randomised controlled trials (RCTs) and quasi‐RCTs of any pharmacological and non‐pharmacological interventions used to treat sexual dysfunction in male and female CKD patients (predialysis, dialysis and kidney transplant) were included. Data collection and analysis Two authors independently selected eligible studies, extracted data and assessed study quality. Disagreements were resolved in consultation with an arbitrator. Treatment effects were summarised as risk ratios (RR), mean differences (MD) or standardised mean difference (SMD) with 95% confidence intervals (CI) using a random‐effects model. Main results Fifteen studies (8 parallel, 7 crossover; 352 patients) were included. Only one study enrolled women. Studies evaluated the effects of phosphodiesterase‐5 inhibitors (PDE5i), zinc, vitamin E, vitamin D or bromocriptine compared to placebo. PDE5i significantly increased the overall International Index of Erectile Function‐5 (IIEF‐5) score (2 studies, 101 patients, MD 10.65, 95% CI 5.34 to 15.96), all its individual domains and the complete 15‐item IIEF tool (1 study, 41 patients, MD 2.64, 95% CI 1.32 to 3.96). End of treatment testosterone levels were not significantly increased by addition of zinc to dialysate (2 studies, 22 patients, MD 0.21 ng/mL, 95% CI ‐2.14 to 2.55) but oral zinc improved end of treatment testosterone levels (1 study, 20 patients, SMD 1.62, 95% CI 0.58 to 2.66). There was no difference in plasma luteinizing and follicle‐stimulating hormone levels at the end of the study period with zinc therapy. Only sparse data were available for vitamin E, bromocriptine and dihydroxycholecalciferol in CKD patients and there were no studies of intracavernous injections, transurethral injections, mechanical devices or psychosexual therapies in people with CKD. Authors' conclusions PDE5i and zinc are promising interventions for treating sexual dysfunction in men with CKD. Evidence supporting their routine use in CKD patients is limited. There is an unmet need for studying interventions for both male and female sexual dysfunction in CKD, considering the significant disease burden." @default.
• W1597521231 created "2016-06-24" @default.
• W1597521231 creator A5003005836 @default.
• W1597521231 creator A5005368649 @default.
• W1597521231 creator A5011147054 @default.
• W1597521231 creator A5035786059 @default.
• W1597521231 creator A5035896202 @default.
• W1597521231 creator A5043394711 @default.
• W1597521231 creator A5051776174 @default.
• W1597521231 creator A5065654610 @default.
• W1597521231 creator A5084907406 @default.
• W1597521231 creator A5088788555 @default.
• W1597521231 date "2010-12-08" @default.
• W1597521231 modified "2023-10-09" @default.
• W1597521231 title "Interventions for treating sexual dysfunction in patients with chronic kidney disease" @default.
• W1597521231 cites W117464322 @default.
• W1597521231 cites W1508412292 @default.
• W1597521231 cites W1511065477 @default.
• W1597521231 cites W1598602811 @default.
• W1597521231 cites W1711733675 @default.
• W1597521231 cites W1898901566 @default.
• W1597521231 cites W1961534087 @default.
• W1597521231 cites W1970593736 @default.
• W1597521231 cites W1971021476 @default.
• W1597521231 cites W1972316401 @default.
• W1597521231 cites W1987095645 @default.
• W1597521231 cites W1996274287 @default.
• W1597521231 cites W1999181000 @default.
• W1597521231 cites W2003394928 @default.
• W1597521231 cites W2003748274 @default.
• W1597521231 cites W2008789239 @default.
• W1597521231 cites W2009682810 @default.
• W1597521231 cites W2013792753 @default.
• W1597521231 cites W2021445538 @default.
• W1597521231 cites W2026664968 @default.
• W1597521231 cites W2026897667 @default.
• W1597521231 cites W2029002373 @default.
• W1597521231 cites W2033333356 @default.
• W1597521231 cites W2035562984 @default.
• W1597521231 cites W2037016482 @default.
• W1597521231 cites W2040141893 @default.
• W1597521231 cites W2042428227 @default.
• W1597521231 cites W2058185307 @default.
• W1597521231 cites W2065135471 @default.
• W1597521231 cites W2067814588 @default.
• W1597521231 cites W2068913937 @default.
• W1597521231 cites W2079319301 @default.
• W1597521231 cites W2084976320 @default.
• W1597521231 cites W2086230995 @default.
• W1597521231 cites W2093087471 @default.
• W1597521231 cites W2093900814 @default.
• W1597521231 cites W2096626963 @default.
• W1597521231 cites W2103036923 @default.
• W1597521231 cites W2108148925 @default.
• W1597521231 cites W2126930838 @default.
• W1597521231 cites W2137451158 @default.
• W1597521231 cites W2139854438 @default.
• W1597521231 cites W2148551246 @default.
• W1597521231 cites W2156770371 @default.
• W1597521231 cites W2156834192 @default.
• W1597521231 cites W2159749658 @default.
• W1597521231 cites W2163797681 @default.
• W1597521231 cites W2165802602 @default.
• W1597521231 cites W2187794078 @default.
• W1597521231 cites W2211219753 @default.
• W1597521231 cites W2312989654 @default.
• W1597521231 cites W2314125128 @default.
• W1597521231 cites W2335397932 @default.
• W1597521231 cites W4212922255 @default.
• W1597521231 cites W4251594861 @default.
• W1597521231 cites W4296981199 @default.
• W1597521231 doi "https://doi.org/10.1002/14651858.cd007747.pub2" @default.
• W1597521231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21154382" @default.
• W1597521231 hasPublicationYear "2010" @default.
• W1597521231 type Work @default.
• W1597521231 sameAs 1597521231 @default.
• W1597521231 citedByCount "20" @default.
• W1597521231 countsByYear W15975212312012 @default.
• W1597521231 countsByYear W15975212312013 @default.
• W1597521231 countsByYear W15975212312014 @default.
• W1597521231 countsByYear W15975212312015 @default.
• W1597521231 countsByYear W15975212312017 @default.
• W1597521231 countsByYear W15975212312020 @default.
• W1597521231 countsByYear W15975212312021 @default.
• W1597521231 countsByYear W15975212312022 @default.
• W1597521231 countsByYear W15975212312023 @default.
• W1597521231 crossrefType "journal-article" @default.
• W1597521231 hasAuthorship W1597521231A5003005836 @default.
• W1597521231 hasAuthorship W1597521231A5005368649 @default.
• W1597521231 hasAuthorship W1597521231A5011147054 @default.
• W1597521231 hasAuthorship W1597521231A5035786059 @default.
• W1597521231 hasAuthorship W1597521231A5035896202 @default.
• W1597521231 hasAuthorship W1597521231A5043394711 @default.
• W1597521231 hasAuthorship W1597521231A5051776174 @default.
• W1597521231 hasAuthorship W1597521231A5065654610 @default.
• W1597521231 hasAuthorship W1597521231A5084907406 @default.
• W1597521231 hasAuthorship W1597521231A5088788555 @default.
• W1597521231 hasConcept C118552586 @default.
• W1597521231 hasConcept C126322002 @default.
• W1597521231 hasConcept C142724271 @default.

• next